Compare ADMA Biologics vs Micromyx
Customers evaluate the quality of ADMA Biologics's products using the following success metrics.
Overview
ADMA Biologics is 20 yrs old and is based in United States.
ADMA is a late stage biopharmaceutical company that develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of certain infectious diseases. ADMA's mission is to develop and commercialize plasma-derived, human immune globulins (IGIV) targeted to niche patient populations for the treatment and prevention of certain infectious diseases, including immune-compromised individuals who suffer from an underlying immune deficiency disease or who may be immune-compromised for medical reasons.
Micromyx is 20 yrs old and is based in United States.
Micromyx is a microbiology services company engaged in anti-infective discovery and development for the pharmaceutical, biotechnology, and animal health industries. Founded in 2004 by former pharmaceutical industry infectious disease scientists, Micromyx is a contract research organization that aims to offer clients documented, top-of-the-line laboratory services from experts who have successfully gained FDA approval of new antibiotics.
Demo Video
Leadership
Adam S Grossman (Chief Executive Officer, President)
Investors
Caligan Partners, R&R Acquisition VI
Southwest Michigan Innovation Center
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because ADMA Biologics has not claimed their profile.
Work for ADMA Biologics? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for ADMA Biologics?
Claim your profile now.
Information not available because Micromyx has not claimed their profile.
Work for Micromyx? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Micromyx?
Claim your profile now.